疟疾治疗市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围:按治疗、给药途径和配销通路
市场调查报告书
商品编码
1389643

疟疾治疗市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围:按治疗、给药途径和配销通路

Malaria Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment, Route of Administration, and Distribution Channel

出版日期: | 出版商: The Insight Partners | 英文 320 Pages | 订单完成后即时交付

价格

疟疾治疗市场预计将从2022年的32.96亿美元成长到2030年的244.87亿美元;预计2022年至2030年复合CAGR为28.5%。由于低收入国家疟疾流行率高以及国际和国家组织发起的全球疟疾消除计划,疟疾治疗市场正在不断增长。此外,先进诊断工具的推出数量不断增加,以及提供有效治疗方法的研究活动不断增加,也进一步推动了市场的成长。然而,假冒抗疟药和随后的抗药性等因素限制了市场的成长。

根据世界卫生组织 (WHO) 最新发布的《2020 年世界疟疾报告》(WMR),全球报告了 2.41 亿例疟疾病例,而 2019 年记录的病例数为 2.27 亿例。疟疾造成的死亡人数每年增加69,000人。其中约三分之二(即 47,000 人)是由于 COVID-19 爆发期间医疗服务中断造成的;其余三分之一的死亡人数,即 22,000 人,反映了世界卫生组织计算疟疾死亡率的方法最近发生的变化(不考虑 COVID-19 的干扰)。

世卫组织非洲区域在全球疟疾负担中所占比例高。 2020 年,全球约 95% 的疟疾病例和约 96% 的死亡发生在非洲,约 80% 的死亡病例为 5 岁及以下儿童。据世界卫生组织称,尼日利亚、坦尚尼亚、刚果民主共和国和莫三比克这四个非洲国家的疟疾相关死亡人数约占全球报告的一半。根据《2020 年柳叶刀区域卫生》报告,非洲国家的疟疾负担最高;恶性疟原虫是导致 5 岁以下儿童死亡率最高的重要原因,占全球约 77%;在非洲国家,恶性疟原虫约占儿童疟疾死亡率的 96%。间日疟原虫占疟疾病例总数的 2%(450 万),主要来自亚洲。根据《WMR 2021》,东南亚国家记录了约 2% 的全球疟疾负担,其中印度占 2020 年估计疟疾病例的 83%,以及 82% 的死亡与疟疾相关。因此,东南亚国家的疟疾盛行率不断上升全球不同地区推动了疟疾治疗市场的成长。

全球疟疾高发国家的政府正在采取各种策略,透过改善人民获得医疗保健服务(包括治疗选择)的机会来根除这种疾病。采取的一些措施如下:

缅甸制定了全球基金批准的国家疟疾控制计划,预计2030年将消除恶性疟原虫引起的疾病。该国的全民健保覆盖还包括透过显微镜或快速诊断测试(RDT)和基于青蒿素的联合疗法(ACT)进行疟疾诊断。

泰国政府实施了2017-2026年国家疟疾消除策略(NMES),进一步实施综合消除策略,旨在在2024年根除这种疾病。

2020年1月,非洲疟疾企业联盟(CAMA)启动了2021-2023年策略计划,旨在透过疟疾控制干预措施惠及数百万人,从而扩大非洲的预防活动。

因此,上述旨在传播疟疾疾病意识的措施加强了根除疟疾的努力,从而促进了疟疾治疗市场的成长。

该报告将疟疾治疗市场细分如下:

根据治疗方法,疟疾治疗市场分为仿製药、原厂药、疫苗等。根据给药途径,疟疾治疗市场分为口服和肠胃外。根据配销通路,疟疾治疗市场分为直接招标、医院药房、零售药房、网路药房等。依地理位置划分,疟疾治疗市场分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、义大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、澳洲、韩国和亚太地区其他地区)、中东和非洲(沙乌地阿拉伯、阿联酋、南非、肯亚、坦尚尼亚、卢安达、奈及利亚、加纳、乌干达、安哥拉、喀麦隆、塞内加尔、尚比亚和其他地区)中东和非洲)以及南美洲和中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。

基于治疗的见解

疟疾治疗市场依治疗分为仿製药、原厂药、疫苗等。疫苗细分市场在 2022 年占据最大的市场份额。疫苗提供针对特定传染病的主动获得性免疫力。由于研发活动的增加和候选疫苗管道的增加,疟疾疫苗市场正在以显着的速度成长。

基于管理的洞察之路

根据给药途径,疟疾治疗市场分为口服、肠胃外和静脉注射。 2022年,口服细分市场占最大市场份额;然而,预计注射剂领域在预测期内的CAGR最高。口服给药是最优选和最合适的给药途径,因为它提供了高患者依从性、非侵入性、最少的无菌限制、成本效益、剂型设计的灵活性以及製造过程的简便性。易于给药和长期成本效益等优点是推动口服药物采用的主要因素。

基于配销通路的见解

根据分销管道,疟疾治疗市场分为直接招标、医院药房、零售药房、网路药房等。 2022年直接招标部分占据最大市场份额;然而,线上药局领域预计在预测期内CAGR最高。口服给药是最优选和最合适的给药途径,因为它提供了高患者依从性、非侵入性、最少的无菌限制、成本效益、剂型设计的灵活性以及製造过程的简便性。易于给药和长期成本效益等优点是推动口服药物采用的主要因素。

在准备疟疾治疗市场报告时提到的一些主要一手和二手来源包括世界卫生组织 (WHO)、美国人口普查局和疾病预防控制中心等。

目录

第 1 章:简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章:执行摘要

  • 主要见解 - 疟疾

第 3 章:研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章:疟疾治疗市场格局

  • 概述
  • PEST 分析 - 疟疾治疗

第 5 章:疟疾治疗市场 - 主要产业动态

  • 主要市场驱动因素:
    • 疟疾盛行率增加
    • 提高人们对疟疾认识的措施不断增多
  • 市场限制
    • 假冒抗疟药物的出现导致抗药性的出现
  • 市场机会
    • 市场参与者不断增加的策略性倡议
  • 未来的趋势
    • 扩大新药和疫苗的研发线
  • 影响分析

第 6 章:疟疾治疗市场 - 全球市场分析

  • 疟疾治疗市场收入,2022 - 2030
  • 地理分析市场收入,2022 - 2030

第 7 章:疟疾治疗市场 - 收入和 2030 年预测 - 按治疗分类

  • 概述
  • 2022 年和 2030 年按治疗分類的疟疾治疗市场收入份额 (%)
  • 疫苗
  • 仿製药
  • 发起人
  • 其他的

第 8 章:疟疾治疗市场 - 2030 年收入和预测 - 按给药途径

  • 概述
  • 2022 年和 2030 年按给药途径分類的疟疾治疗市场收入份额 (%)
  • 口服
  • 注射用

第 9 章:疟疾治疗市场 - 2030 年收入和预测 - 按配销通路

  • 概述
  • 2022 年和 2030 年按配销通路分類的疟疾治疗市场收入份额 (%)
  • 直接招标
  • 医院药房
  • 零售药局
  • 网路药局
  • 其他的

第 10 章:疟疾治疗市场 - 地理分析

  • 北美洲
      • 我们
      • 加拿大
      • 墨西哥
  • 欧洲
    • 法国
    • 英国
    • 义大利
    • 德国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
    • 肯亚
    • 坦尚尼亚
    • 盧安达
    • 奈及利亚
    • 迦纳
    • 乌干达
    • 安哥拉
    • 喀麦隆
    • 塞内加尔
    • 尚比亚
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章:疟疾治疗市场产业格局

  • 概述
  • 疟疾治疗市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章:公司简介

  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • AdvaCare Pharma USA LLC
  • VLP Therapeutics LLC
  • Lupin Ltd

第 13 章:附录

  • 关于我们
  • 专业术语

第 14 章:附录

Product Code: TIPRE00018229

The malaria treatment market is expected to grow from US$ 3.296 billion in 2022 to US$ 24.487 billion by 2030; it is estimated to grow at a CAGR of 28.5% from 2022 to 2030. The market for malaria treatment is growing due to the high prevalence of malaria in low-income countries and global malaria elimination programs initiated by international and national organizations. Also, the increasing number of launches of advanced diagnostic tools and rising research activities to provide effective therapeutics are further driving the growth of the market. However, factors such as a counterfeit antimalarial drug and subsequent drug resistance are restraining the market growth.

According to the latest World Malaria Report (WMR) 2020 from the World Health Organization (WHO), 241 million cases of malaria were reported in the world, in comparison to 227 million cases that were logged in 2019. According to the same source, the number of deaths caused due to malaria has an annual rise of 69,000 deaths. Approximately two-thirds of these deaths, i.e., 47,000, were caused by disruptions in healthcare services during the COVID-19 outbreak; the remaining one-third of deaths, i.e., 22,000 reflected a recent change in the WHO's methodology for calculating malaria mortality (irrespective of COVID-19 disruptions).

The WHO African region accounted for a high share of the global burden of malaria. In 2020, ~95% of global cases and ~96% of deaths were reported in Africa due to malaria, and ~80% of the total deaths that were reported were in children aged 5 and below. According to the WHO, four African countries, Nigeria, Tanzania, the Democratic Republic of the Congo, and Mozambique, recorded approximately half of all malaria-related deaths that were reported globally. According to the LANCET Regional Health 2020, African countries had the highest burden of malaria; P. falciparum is a notable cause of the highest mortality rates in children younger than 5, which accounts for ~77% across the world; in African countries, P. falciparum accounts for ~96% of total mortalities caused among children by malaria. P. vivax has been a causal agent of 2% (4.5 million) of the total cases of malaria, mainly from Asia. According to WMR 2021, ~2% of the global burden of malaria was recorded by Southeast Asian countries, where India accounted for 83% of estimated malaria cases and 82% of deaths associate with malaria in 2020. Thus, the rising prevalence of malaria in different regions across the globe boosts the malaria treatment market growth.

Governments of various countries across the globe with a high prevalence of malaria are deploying various strategies to eradicate the disease by improving access to healthcare services, including treatment options, to the people. A few of the initiatives undertaken are as follows:

Myanmar has a national malaria control plan that the Global Fund has approved, and by 2030, it is expected to eliminate the disease caused by P. falciparum. The universal healthcare coverage in the country also includes access to malaria diagnosis by means of microscopy or rapid diagnostic tests (RDTs) and artemisinin-based combination therapies (ACTs).

The government of Thailand has implemented a National Malaria Elimination Strategy (NMES) 2017-2026 that further applies an integrated elimination strategy that aims to eradicate the disease by 2024.

In January 2020, the Corporate Alliance on Malaria in Africa (CAMA) launched a strategic plan for 2021-2023 with an aim to reach millions of people through malaria control interventions and thereby scale up prevention activities in Africa.

Thus, the abovementioned initiatives to spread awareness about malaria disease reinforce the eradication efforts to bolster the malaria treatment market growth.

The report segments the malaria treatment market as follows:

Based on treatment, the malaria treatment market is segmented into generic drugs, originators, vaccines, and others. Based on route of administration, the malaria treatment market is divided into oral and parenteral. Based on distribution channel, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. By geography, the malaria treatment market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, Kenya, Tanzania, Rwanda, Nigeria, Ghana, Uganda, Angola, Cameroon, Senegal, Zambia, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Treatment-Based Insights

The malaria treatment market is segmented based on treatment into generic drugs, originators, vaccines, and others. vaccines segment held the largest market share in 2022. Vaccines provide active acquired immunity against particular infectious disease. The market for malaria vaccines is growing at a significant growth rate owing to increasing research and development activities and increasing pipeline of vaccine candidates.

Route of Administration-Based Insights

Based on route of administration, the malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment accounted for the largest share of the market in 2022; however, the parenteral segment is expected to register the highest CAGR during the forecast period. Oral drug delivery is the most preferred and suitable route of drug administration as it offers high patient compliance, non-invasiveness, least sterility constraints, cost-effectiveness, flexibility in the design of dosage form and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are major factors fueling the adoption of oral drugs.

Distribution Channel-Based Insights

Based on distribution channels, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment accounted for the largest share of the market in 2022; however, the online pharmacies segment is expected to register the highest CAGR during the forecast period. Oral drug delivery is the most preferred and suitable route of drug administration as it offers high patient compliance, non-invasiveness, least sterility constraints, cost-effectiveness, flexibility in the design of dosage form and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are major factors fueling the adoption of oral drugs.

A few of the major primary and secondary sources referred to while preparing the report on the malaria treatment market are the World Health Organization (WHO), the US Census Bureau, and CDC, among others.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the malaria treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights - Malaria

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Malaria Treatment Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis - Malaria Treatment

5. Malaria Treatment Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Prevalence of Malaria
    • 5.1.2 Rising Initiatives to Raise Awareness about Malaria
  • 5.2 Market Restraints
    • 5.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
  • 5.3 Market Opportunities
    • 5.3.1 Growing Strategic Initiatives by Market Players
  • 5.4 Future Trends
    • 5.4.1 Extending Pipeline of New Drugs and Vaccines
  • 5.5 Impact Analysis

6. Malaria Treatment Market - Global Market Analysis

  • 6.1 Malaria Treatment Market Revenue (US$ million), 2022 - 2030
  • 6.2 Geography Analysis Market Revenue (US$ million), 2022 - 2030

7. Malaria Treatment Market - Revenue and Forecast to 2030 - by Treatment

  • 7.1 Overview
  • 7.2 Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
  • 7.3 Vaccines
    • 7.3.1 Overview
    • 7.3.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.4 Generic Drugs
    • 7.4.1 Overview
    • 7.4.2 Generic Drugs Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.5 Originators
    • 7.5.1 Overview
    • 7.5.2 Originators Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8. Malaria Treatment Market - Revenue and Forecast to 2030 - by Route of Administration

  • 8.1 Overview
  • 8.2 Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
  • 8.3 Oral
    • 8.3.1 Overview
    • 8.3.2 Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Parenteral
    • 8.4.1 Overview
    • 8.4.2 Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Malaria Treatment Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Direct Tender
    • 9.3.1 Overview
    • 9.3.2 Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Hospital Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Hospital Pharmacies: Malaria Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.4.2.1.1 Malaria Treatment Market, by Hospital Pharmacies
  • 9.5 Retail Pharmacies
    • 9.5.1 Overview
    • 9.5.2 Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.5.2.1.1 Malaria Treatment Market, by Retail Pharmacies
  • 9.6 Online Pharmacies
    • 9.6.1 Overview
    • 9.6.2 Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others : Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. Malaria Treatment Market - Geographical Analysis

  • 10.1 North America Malaria Treatment Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.1 North America: Malaria Treatment Market, by Treatment
      • 10.1.2.2 North America: Malaria Treatment Market, by Route of Administration
      • 10.1.2.3 North America: Malaria Treatment Market, by Distribution Channel
        • 10.1.2.3.1 North America: Malaria Treatment Market, by Hospital Pharmacies
        • 10.1.2.3.2 North America: Malaria Treatment Market, by Retail Pharmacies
      • 10.1.2.4 North America: Malaria Treatment Market, by Country
      • 10.1.2.5 US
      • 10.1.2.6 Overview
        • 10.1.2.6.1 US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.2 US: Malaria Treatment Market, by Treatment
        • 10.1.2.6.3 US: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.1.2.6.4 US: Malaria Treatment Market, by Distribution Channel
        • 10.1.2.6.4.1 US: Malaria Treatment Market, by Hospital Pharmacies
        • 10.1.2.6.4.2 US: Malaria Treatment Market, by Retail Pharmacies
      • 10.1.2.7 Canada
      • 10.1.2.8 Overview
        • 10.1.2.8.1 Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.8.2 Canada: Malaria Treatment Market, by Treatment
        • 10.1.2.8.3 Canada: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.1.2.8.4 Canada: Malaria Treatment Market, by Distribution Channel
        • 10.1.2.8.4.1 Canada: Malaria Treatment Market, by Hospital Pharmacies
        • 10.1.2.8.4.2 Canada: Malaria Treatment Market, by Retail Pharmacies
      • 10.1.2.9 Mexico
      • 10.1.2.10 Overview
        • 10.1.2.10.1 Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.10.2 Mexico: Malaria Treatment Market, by Treatment
        • 10.1.2.10.3 Mexico: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.1.2.10.4 Mexico: Malaria Treatment Market, by Distribution Channel
        • 10.1.2.10.4.1 Mexico: Malaria Treatment Market, by Hospital Pharmacies
        • 10.1.2.10.4.2 Mexico: Malaria Treatment Market, by Retail Pharmacies
  • 10.2 Europe Malaria Treatment Market, Revenue and Forecast To 2030
    • 10.2.1 Overview
    • 10.2.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.2.2.1 Europe: Malaria Treatment Market, by Treatment
      • 10.2.2.2 Europe: Malaria Treatment Market, by Route of Administration
      • 10.2.2.3 Europe: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.3.1 Europe: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.3.2 Europe: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.4 Europe: Malaria Treatment Market, by Countries
      • 10.2.2.5 France
      • 10.2.2.6 Overview
        • 10.2.2.6.1 France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.6.2 France: Malaria Treatment Market, by Treatment
        • 10.2.2.6.3 France: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.6.4 France: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.6.4.1 France: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.6.4.2 France: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.7 UK
      • 10.2.2.8 Overview
        • 10.2.2.8.1 UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.8.2 UK: Malaria Treatment Market, by Treatment
        • 10.2.2.8.3 UK: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.8.4 UK: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.8.4.1 UK: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.8.4.2 UK: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.9 Italy
      • 10.2.2.10 Overview
        • 10.2.2.10.1 Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.10.2 Italy: Malaria Treatment Market, by Treatment
        • 10.2.2.10.3 Italy: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.10.4 Italy: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.10.4.1 Italy: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.10.4.2 Italy: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.11 Germany
      • 10.2.2.12 Overview
        • 10.2.2.12.1 Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.12.2 Germany: Malaria Treatment Market, by Treatment
        • 10.2.2.12.3 Germany: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.12.4 Germany: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.12.4.1 Germany: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.12.4.2 Germany: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.13 Spain
      • 10.2.2.14 Overview
        • 10.2.2.14.1 Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.14.2 Spain: Malaria Treatment Market, by Treatment
        • 10.2.2.14.3 Spain: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.14.4 Spain: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.14.4.1 Spain: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.14.4.2 Spain: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.15 Rest of Europe
      • 10.2.2.16 Overview
        • 10.2.2.16.1 Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.16.2 Rest of Europe: Malaria Treatment Market, by Treatment
        • 10.2.2.16.3 Rest of Europe: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.16.4 Rest of Europe: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.16.4.1 Rest of Europe: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.16.4.2 Rest of Europe: Malaria Treatment Market, by Retail Pharmacies
  • 10.3 Asia Pacific Malaria Treatment Market, Revenue and Forecast To 2030
    • 10.3.1 Overview
    • 10.3.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.3.2.1 Asia Pacific: Malaria Treatment Market, by Treatment
      • 10.3.2.2 Asia Pacific: Malaria Treatment Market, by Route of Administration
      • 10.3.2.3 Asia Pacific: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.3.1 Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.3.2 Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.2.4 Asia Pacific: Malaria Treatment Market, by Countries
      • 10.3.2.5 Japan
      • 10.3.2.6 Overview
        • 10.3.2.6.1 Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.6.2 Japan: Malaria Treatment Market, by Treatment
        • 10.3.2.6.3 Japan: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.2.6.4 Japan: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.6.4.1 Japan: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.6.4.2 Japan: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.2.7 India
      • 10.3.2.8 Overview
        • 10.3.2.8.1 India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.8.2 India: Malaria Treatment Market, by Treatment
        • 10.3.2.8.3 India: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.2.8.4 India: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.8.4.1 India: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.8.4.2 India: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.2.9 South Korea
      • 10.3.2.10 Overview
        • 10.3.2.10.1 South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.10.2 South Korea: Malaria Treatment Market, by Treatment
        • 10.3.2.10.3 South Korea: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.2.10.4 South Korea: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.10.4.1 South Korea: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.10.4.2 South Korea: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.2.11 Australia
      • 10.3.2.12 Overview
        • 10.3.2.12.1 Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.12.2 Australia: Malaria Treatment Market, by Treatment
        • 10.3.2.12.3 Australia: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.2.12.4 Australia: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.12.4.1 Australia: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.12.4.2 Australia: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.2.13 Rest of Asia Pacific
      • 10.3.2.14 Overview
        • 10.3.2.14.1 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.14.2 Rest of Asia Pacific: Malaria Treatment Market, by Treatment
        • 10.3.2.14.3 Rest of Asia Pacific: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.2.14.4 Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.14.4.1 Rest of Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.14.4.2 Rest of Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
  • 10.4 Middle East & Africa Malaria Treatment Market, Revenue and Forecast To 2030
    • 10.4.1 Overview
    • 10.4.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.4.2.1 Middle East & Africa: Malaria Treatment Market, by Treatment
      • 10.4.2.2 Middle East & Africa: Malaria Treatment Market, by Route of Administration
      • 10.4.2.3 Middle East & Africa: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.3.1 Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.3.2 Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.4 Middle East & Africa: Malaria Treatment Market, by Country
      • 10.4.2.5 Saudi Arabia
      • 10.4.2.6 Overview
        • 10.4.2.6.1 Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.6.2 Saudi Arabia: Malaria Treatment Market, by Treatment
        • 10.4.2.6.3 Saudi Arabia: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.6.4 Saudi Arabia: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.6.4.1 Saudi Arabia: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.6.4.2 Saudi Arabia: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.7 UAE
      • 10.4.2.8 Overview
        • 10.4.2.8.1 UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.8.2 UAE: Malaria Treatment Market, by Treatment
        • 10.4.2.8.3 UAE: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.8.4 UAE: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.8.4.1 UAE: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.8.4.2 UAE: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.9 South Africa
      • 10.4.2.10 Overview
        • 10.4.2.10.1 South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.10.2 South Africa: Malaria Treatment Market, by Treatment
        • 10.4.2.10.3 South Africa: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.10.4 South Africa: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.10.4.1 South Africa: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.10.4.2 South Africa: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.11 Kenya
      • 10.4.2.12 Overview
        • 10.4.2.12.1 Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.12.2 Kenya: Malaria Treatment Market, by Treatment
        • 10.4.2.12.3 Kenya: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.12.4 Kenya: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.12.4.1 Kenya: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.12.4.2 Kenya: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.13 Tanzania
      • 10.4.2.14 Overview
        • 10.4.2.14.1 Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.14.2 Tanzania: Malaria Treatment Market, by Treatment
        • 10.4.2.14.3 Tanzania: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.14.4 Tanzania: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.14.4.1 Tanzania: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.14.4.2 Tanzania: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.15 Rwanda
      • 10.4.2.16 Overview
        • 10.4.2.16.1 Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.16.2 Rwanda: Malaria Treatment Market, by Treatment
        • 10.4.2.16.3 Rwanda: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.16.4 Rwanda: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.16.4.1 Rwanda: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.16.4.2 Rwanda: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.17 Nigeria
      • 10.4.2.18 Overview
        • 10.4.2.18.1 Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.18.2 Nigeria: Malaria Treatment Market, by Treatment
        • 10.4.2.18.3 Nigeria: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.18.4 Nigeria: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.18.4.1 Nigeria: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.18.4.2 Nigeria: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.19 Ghana
      • 10.4.2.20 Overview
        • 10.4.2.20.1 Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.20.2 Ghana: Malaria Treatment Market, by Treatment
        • 10.4.2.20.3 Ghana: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.20.4 Ghana: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.20.4.1 Ghana: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.20.4.2 Ghana: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.21 Uganda
      • 10.4.2.22 Overview
        • 10.4.2.22.1 Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.22.2 Uganda: Malaria Treatment Market, by Treatment
        • 10.4.2.22.3 Uganda: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.22.4 Uganda: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.22.4.1 Uganda: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.22.4.2 Uganda: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.23 Angola
      • 10.4.2.24 Overview
        • 10.4.2.24.1 Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.24.2 Angola: Malaria Treatment Market, by Treatment
        • 10.4.2.24.3 Angola: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.24.4 Angola: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.24.4.1 Angola: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.24.4.2 Angola: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.25 Cameroon
      • 10.4.2.26 Overview
        • 10.4.2.26.1 Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.26.2 Cameroon: Malaria Treatment Market, by Treatment
        • 10.4.2.26.3 Cameroon: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.26.4 Cameroon: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.26.4.1 Cameroon: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.26.4.2 Cameroon: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.27 Senegal
      • 10.4.2.28 Overview
        • 10.4.2.28.1 Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.28.2 Senegal: Malaria Treatment Market, by Treatment
        • 10.4.2.28.3 Senegal: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.28.4 Senegal: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.28.4.1 Senegal: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.28.4.2 Senegal: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.29 Zambia
      • 10.4.2.30 Overview
        • 10.4.2.30.1 Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.30.2 Zambia: Malaria Treatment Market, by Treatment
        • 10.4.2.30.3 Zambia: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.30.4 Zambia: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.30.4.1 Zambia: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.30.4.2 Zambia: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.31 Rest of Middle East & Africa
      • 10.4.2.32 Overview
        • 10.4.2.32.1 Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.32.2 Rest of Middle East & Africa: Malaria Treatment Market, by Treatment
        • 10.4.2.32.3 Rest of Middle East & Africa: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.32.4 Rest of Middle East & Africa: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.32.4.1 Rest of Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.32.4.2 Rest of Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
  • 10.5 South & Central America Malaria Treatment Market, Revenue and Forecast To 2030
    • 10.5.1 Overview
    • 10.5.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.5.2.1 South & Central America: Malaria Treatment Market, by Treatment
      • 10.5.2.2 South & Central America: Malaria Treatment Market, by Route of Administration
      • 10.5.2.3 South & Central America: Malaria Treatment Market, by Distribution Channel
        • 10.5.2.3.1 South & Central America: Malaria Treatment Market, by Hospital Pharmacies
        • 10.5.2.3.2 South & Central America: Malaria Treatment Market, by Retail Pharmacies
      • 10.5.2.4 South & Central America: Malaria Treatment Market, by Countries
      • 10.5.2.5 Brazil
      • 10.5.2.6 Overview
        • 10.5.2.6.1 Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.2.6.2 Brazil: Malaria Treatment Market, by Treatment
        • 10.5.2.6.3 Brazil: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.5.2.6.4 Brazil: Malaria Treatment Market, by Distribution Channel
        • 10.5.2.6.4.1 Brazil: Malaria Treatment Market, by Hospital Pharmacies
        • 10.5.2.6.4.2 Brazil: Malaria Treatment Market, by Retail Pharmacies
      • 10.5.2.7 Argentina
      • 10.5.2.8 Overview
      • 10.5.2.9 Rest of South & Central America
      • 10.5.2.10 Overview
        • 10.5.2.10.1 Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.2.10.2 Rest of South & Central America: Malaria Treatment Market, by Treatment
        • 10.5.2.10.3 Rest of South & Central America: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.5.2.10.4 Rest of South & Central America: Malaria Treatment Market, by Distribution Channel
        • 10.5.2.10.4.1 Rest of South & Central America: Malaria Treatment Market, by Hospital Pharmacies
        • 10.5.2.10.4.2 Rest of South & Central America: Malaria Treatment Market, by Retail Pharmacies

11. Malaria Treatment Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Malaria Treatment Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Cipla Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Sun Pharmaceutical Industries Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Sanofi SA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 GSK Plc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Novartis AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Pfizer Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Service
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 AdvaCare Pharma USA LLC
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 VLP Therapeutics LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Lupin Ltd
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

14. Appendix

List Of Tables

  • Table 1. Malaria Treatment Market Segmentation
  • Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
  • Table 3. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 4. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
  • Table 5. North America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 6. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 7. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 8. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 9. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 10. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 11. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 12. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 13. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 14. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 15. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 16. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 17. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 18. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 19. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 20. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 21. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 22. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 23. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 24. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 25. Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 26. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 27. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 28. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 29. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 30. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 31. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 32. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 33. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 34. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 35. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 36. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 37. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 38. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 39. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 40. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 41. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 42. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 43. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 44. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 45. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 46. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 47. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 48. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 49. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 50. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 51. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 52. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 53. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 54. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 55. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 56. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 57. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 58. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 59. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 60. Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 61. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 62. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 63. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 64. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 65. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 66. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 67. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 68. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 69. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 70. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 71. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 72. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 73. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 74. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 75. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 76. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 77. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 78. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 79. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 80. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 81. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 82. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 83. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 84. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 85. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 86. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 87. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 88. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 89. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 90. Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 91. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 92. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 93. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 94. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 95. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 96. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 97. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 98. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 99. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 100. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 101. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 102. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 103. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 104. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 105. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 106. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 107. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 108. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 109. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 110. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 111. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 112. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 113. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 114. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 115. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 116. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 117. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 118. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 119. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 120. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 121. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 122. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 123. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 124. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 125. Nigeria Malaria Treatment Market, by Treatment - Revenue and Forecast to 2030 (USD Million)
  • Table 126. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 127. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 128. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 129. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 130. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 131. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 132. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 133. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 134. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 135. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 136. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 137. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 138. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 139. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 140. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 141. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 142. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 143. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 144. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 145. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 146. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 147. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 148. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 149. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 150. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 151. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 152. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 153. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 154. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 155. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 156. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 157. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 158. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 159. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 160. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 161. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 162. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 163. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 164. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 165. South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 166. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 167. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 168. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 169. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 170. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 171. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 172. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 173. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 174. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 175. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 176. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 177. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 178. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 179. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 180. Recent Inorganic Growth Strategies in the Malaria Treatment Market
  • Table 181. Recent Organic Growth Strategies in the Malaria Treatment Market
  • Table 182. Glossary of Terms, Malaria Treatment Market

List Of Figures

  • Figure 1. PEST Analysis - Malaria
  • Figure 2. Malaria Treatment Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Malaria Treatment Market Revenue (US$ million), 2020 - 2030
  • Figure 5. Malaria: Geography Analysis Market Revenue (US$ million), 2022 - 2030
  • Figure 6. Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
  • Figure 7. Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 8. Generic Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 9. Originators Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 10. Others Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 11. Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
  • Figure 12. Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 15. Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hospital Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Malaria Treatment Market, By Geography, 2022 ($Mn)
  • Figure 21. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 22. North America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 23. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Europe Malaria Treatment Market, By Geography, 2022 ($Mn)
  • Figure 27. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Europe: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 29. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. Malaria Treatment Market, 2022 ($Mn)
  • Figure 36. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Asia Pacific: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 38. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 40. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 42. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Malaria Treatment Market, 2022 (US$ Mn)
  • Figure 44. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Middle East & Africa: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 46. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 49. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 51. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 53. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 56. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 58. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 60. Malaria Treatment Market, 2022 ($Mn)
  • Figure 61. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 62. South & Central America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 63. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 64. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 65. Growth Strategies in the Malaria Treatment Market